Filter News
Area of Research
- (-) Biology and Environment (19)
- (-) Nuclear Science and Technology (7)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Clean Energy (17)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (2)
- Isotopes (5)
- Materials (39)
- Materials for Computing (7)
- National Security (6)
- Neutron Science (99)
- Supercomputing (26)
News Topics
- (-) Biomedical (18)
- (-) Neutron Science (9)
- 3-D Printing/Advanced Manufacturing (15)
- Advanced Reactors (12)
- Artificial Intelligence (9)
- Big Data (9)
- Bioenergy (46)
- Biology (73)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (11)
- Climate Change (40)
- Composites (5)
- Computer Science (21)
- Coronavirus (14)
- Critical Materials (1)
- Cybersecurity (2)
- Decarbonization (20)
- Energy Storage (7)
- Environment (90)
- Exascale Computing (4)
- Frontier (3)
- Fusion (9)
- Grid (3)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (7)
- Machine Learning (8)
- Materials (12)
- Materials Science (9)
- Mathematics (3)
- Mercury (7)
- Microscopy (10)
- Molten Salt (5)
- Nanotechnology (7)
- National Security (3)
- Net Zero (2)
- Nuclear Energy (37)
- Partnerships (5)
- Physics (4)
- Polymers (2)
- Renewable Energy (1)
- Security (2)
- Simulation (14)
- Space Exploration (5)
- Summit (10)
- Sustainable Energy (31)
- Transformational Challenge Reactor (4)
- Transportation (3)
Media Contacts
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory scientists for Early Career Research Program awards.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
With Tennessee schools online for the rest of the school year, researchers at ORNL are making remote learning more engaging by “Zooming” into virtual classrooms to tell students about their science and their work at a national laboratory.